इसराइल - अंग्रेज़ी - Ministry of Health

novartis israel ltd - omalizumab - powder and solvent for solution for injection - omalizumab 150 mg/dose - omalizumab - omalizumab - allergic asthma xolair is indicated for patients 6 to 12 years of age with severe persistent asthma and for patients 12 years of age and older with moderate to severe persistent asthma, who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. limitations of use: xolair is not indicated for the relief of acute bronchospasm or status asthmaticus. xolair is not indicated for the treatment of other allergic conditions.chronic rhinosinusitis with nasal polyps (crswnp) xolair is indicated as an add-on therapy with intranasal corticosteroids (inc) for the treatment of adults (18 years and above) with severe crswnp for whom therapy with inc does not provide adequate disease control.chronic spontaneous urticaria (csu) xolair is indicated as add-on therapy for the treatment of chronic spontaneous urticaria in adult and adolescent (12 years and above) patients with inadequate response to h1 antihistamine treatment.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals australia pty ltd - imiquimod -

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - imiquimod -

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - imiquimod, quantity: 12.5 mg - cream - excipient ingredients: benzyl alcohol; purified water; methyl hydroxybenzoate; isostearic acid; xanthan gum; glycerol; white soft paraffin; polysorbate 60; stearyl alcohol; propyl hydroxybenzoate; sorbitan monostearate; cetyl alcohol - ? treatment of solar (actinic) keratosis on the face and scalp (see precautions), and ,? primary treatment of confirmed superficial basal cell carcinoma where surgery is considered inappropriate, and ,? treatment of external genital and perianal warts/condyloma acuminata in adults (see precautions).

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

kerr australia pty ltd - 35875 - dental material, filling/restorative, polymer based - a dental material used as a color modifier and opaquer underneath or between layers of composite restoration materials.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - imiquimod 5%{relative};   - topical cream - 5% w/w - active: imiquimod 5%{relative}   excipient: benzyl alcohol cetyl alcohol glycerol methyl hydroxybenzoate polysorbate 60 propyl hydroxybenzoate purified water sorbitan stearate stearic acid stearyl alcohol white soft paraffin xanthan gum

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

apotex nz ltd - imiquimod 12.5mg - topical cream - 5% w/w - active: imiquimod 12.5mg excipient: benzyl alcohol cetyl alcohol glycerol isostearic acid methyl hydroxybenzoate polysorbate 60 propyl hydroxybenzoate purified water sorbitan stearate stearyl alcohol white soft paraffin xanthan gum - indicated for the topical treatment of actinic keratosis on the face and scalp in immunocompetent adults.

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

boehringer ingelheim international gmbh - tiotropium - inhalation solution - 2.5 microgram(s) - anticholinergics; tiotropium bromide

सिंगापुर - अंग्रेज़ी - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - omalizumab - injection, powder, lyophilized, for solution - 150mg - omalizumab 150mg